# Montel Williams & Dr. Benjamin Caplan: Multiple Sclerosis & Severe Chronic Pain

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/videos/montel-williams-chronic-illness-ms/
> **Published:** 2026-10-08T15:45:32-04:00 | **Last Modified / Clinically Audited:** 2026-10-30T14:41:46-04:00
> **Clinical Summary:** Three-part broadcast dialogue between Montel Williams and Dr. Benjamin Caplan on managing multiple sclerosis, neuropathic pain, and severe chronic illness.

---

[← All Videos & Media](/videos/)
 3-Part Broadcast Anthology
 
 

Table of Contents

- [Montel Williams & Dr. Benjamin Caplan:The Complete Medical Cannabis & Chronic Illness Anthology](#Montel_Williams_038_Dr_Benjamin_CaplanThe_Complete_Medical_Cannabis_038_Chronic_Illness_Anthology)[CANNABIS CARE | BENJAMIN CAPLAN, M.D.](#CANNABIS_CARE_BENJAMIN_CAPLAN_MD)
- [DOCTOR APPROVED CANNABIS | BENJAMIN CAPLAN, MD](#DOCTOR_APPROVED_CANNABIS_BENJAMIN_CAPLAN_MD)
- [Pain to Relief: Dr Caplan and Cannabis Patient Burnadett Preaster](#Pain_to_Relief_Dr_Caplan_and_Cannabis_Patient_Burnadett_Preaster)
- [Cannabinoid Therapeutics in Neuroinflammatory Illness](#Cannabinoid_Therapeutics_in_Neuroinflammatory_Illness)[🧠 Neuroprotection & Myelin Shielding](#_Neuroprotection_038_Myelin_Shielding)
- [⚡ Central Spasticity & Motor Equilibrium](#_Central_Spasticity_038_Motor_Equilibrium)
- [🔥 Neuropathic Fire Extinguishment](#_Neuropathic_Fire_Extinguishment)
- [💊 De-Prescribing & Polypharmacy Relief](#_De-Prescribing_038_Polypharmacy_Relief)
- [Cannabis in Pediatric Autism: Speech Emergence & Calming Science](#Cannabis_in_Pediatric_Autism_Speech_Emergence_038_Calming_Science)
- [Montel’s Courage Bridges Patient Experience and Frontline Medicine](#Montels_Courage_Bridges_Patient_Experience_and_Frontline_Medicine)[Swapping Pills for Pot: Opioid Sparing & Harm Reduction](#Swapping_Pills_for_Pot_Opioid_Sparing_038_Harm_Reduction)
- [Explore the CĒD Clinic Video Network](#Explore_the_CED_Clinic_Video_Network)[Swapping Pills for Pot: Opioid Sparing](#Swapping_Pills_for_Pot_Opioid_Sparing)
- [Ethan Zohn & Dr. Caplan: Cancer Recovery](#Ethan_Zohn_038_Dr_Caplan_Cancer_Recovery)
- [Pediatric Autism & Cannabinoid Therapy](#Pediatric_Autism_038_Cannabinoid_Therapy)
- [The Master Media Timeline (2018–2026)](#The_Master_Media_Timeline_20182026)
- [Consult on Multiple Sclerosis & Neuropathy Care](#Consult_on_Multiple_Sclerosis_038_Neuropathy_Care)[Recent Clinical Trials & Peer-Reviewed Evidence: Multiple sclerosis](#Recent_Clinical_Trials_Peer-Reviewed_Evidence_Multiple_sclerosis)[Nabiximols in Multiple Sclerosis: Beyond Spasticity—An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes](#Nabiximols_in_Multiple_Sclerosis_Beyond_SpasticityAn_Exploratory_Systematic_Review_and_Meta-Analysis_of_Symptomatic_Outcomes)
- [Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation](#Cannabidiol_causes_endothelium-dependent_vasorelaxation_of_human_mesenteric_arteries_via_CB1_activation)

# Montel Williams & Dr. Benjamin Caplan:The Complete Medical Cannabis & Chronic Illness Anthology

 

Three in-depth broadcast dialogues on *Let’s Be Blunt with Montel*. Emmy-winning television host and pioneering MS advocate Montel Williams sits down with Dr. Benjamin Caplan across multiple landmark episodes to explore 250,000+ clinical patient evaluations, *The Doctor-Approved Cannabis Handbook*, and real-world patient relief.

 
 🎗️ 3 Full Broadcast Episodes
 🧠 Multiple Sclerosis & Spasticity
 📖 The Cannabis Handbook Launch
 🩺 Patient Case Study: Burnadett Preaster
 
 
 
 Jump to Episode:
 [1️⃣ Ep 1: Cannabis Care ↗](#episode-1)
 [2️⃣ Ep 2: Doctor Approved Cannabis ↗](#episode-2)
 [3️⃣ Ep 3: Pain to Relief (Patient Study) ↗](#episode-3)
 
 
 
 
 
 
 ● Episode 1 | Premiere Clinical Feature
 Let’s Be Blunt with Montel
 
 
 
 
 
 Episode 1: The Clinical Practice Model
 

### CANNABIS CARE | BENJAMIN CAPLAN, M.D.

 

In their flagship sit-down, Montel Williams introduces Dr. Benjamin Caplan as one of the nation’s premier cannabis medical authorities, having overseen evaluations for over 250,000 patients. Montel shares his personal journey surviving relapsing-remitting multiple sclerosis (diagnosed in 1999), and together they break down why conventional medicine fails [chronic pain](https://cedclinic.com/cbd-gummies-chronic-pain/) patients: over-relying on synthetic opioids and sedatives while ignoring the physiological power of whole-plant endocannabinoid signaling.

 “Patients don’t need massive doses of intoxicating THC; they need precision ratios of cannabinoids and terpenes tailored to their unique neurological receptor deficiency.” — Dr. Benjamin Caplan, MD
 
 [Watch Episode 1 on YouTube ↗](https://www.youtube.com/watch?v=dx8f2fDCe9g)
 [Book MS & Neuropathy Consultation ↗](https://cedclinic.com/contact-ced-staff/)
 
 
 
 
 
 
 
 
 ● Episode 2 | Landmark Handbook Discussion
 Let’s Be Blunt with Montel
 
 
 
 
 
 Episode 2: The Doctor-Approved Cannabis Handbook
 

### DOCTOR APPROVED CANNABIS | BENJAMIN CAPLAN, MD

 

Dr. Caplan returns to *Let’s Be Blunt* to celebrate the release of his definitive medical guide, *The Doctor-Approved Cannabis Handbook* (Penguin Random House). Montel and Dr. Caplan dismantle commercial cannabis myths, expose dispensary product mislabeling, and discuss how patients can systematically self-titrate using microdosing, sublingual delivery, and minor cannabinoids (CBG, CBN, THCV) to treat refractory chronic symptoms without intoxication.

 “The dispensary budtender is not a medical professional. Our goal with the handbook is to give patients the exact scientific roadmap their doctors were never taught in medical school.” — Dr. Benjamin Caplan, MD
 
 [Watch Episode 2 on YouTube ↗](https://www.youtube.com/watch?v=tH1Wpj4HT-Y)
 [Order The Cannabis Handbook ↗](https://www.DoctorApprovedCannabisHandbook.com)
 
 
 
 
 
 
 
 
 ● Episode 3 | Real Patient Case Study
 Let’s Be Blunt with Montel
 
 
 
 
 
 Episode 3: Patient Journey & Clinical Triumph
 

### Pain to Relief: Dr Caplan and Cannabis Patient Burnadett Preaster

 

Montel Williams hosts a groundbreaking case-study dialogue bringing Dr. Benjamin Caplan together with [medical cannabis](https://cedclinic.com/cbd-gummies-for-sexual-enhancement-evidence/) patient Burnadett Preaster. Burnadett details her harrowing journey living with severe chronic back pain, failed spinal treatments, and the heavy burden of prescription pain pills. Under Dr. Caplan’s clinical supervision, Burnadett successfully transitioned to medical cannabis, reclaiming her physical mobility, daily energy, and sleep without cognitive fog.

 “Listening to Burnadett is a reminder of why we do this work. When a patient goes from despair and medication dependence to vibrant living, it proves that clinician-guided cannabinoid medicine transforms lives.” — Montel Williams
 
 [Watch Episode 3 on YouTube ↗](https://www.youtube.com/watch?v=esCxNaeZMU0)
 [Schedule Your Pain Case Review ↗](https://cedclinic.com/contact-ced-staff/)
 
 
 
 
 
 
 
 Neurological Mechanisms
 

## Cannabinoid Therapeutics in Neuroinflammatory Illness

 

Understanding the cellular pathways that calm spasticity, quench neuropathic fires, and preserve cognitive integrity.

 
 
 
 Immune Modulation
 

#### 🧠 Neuroprotection & Myelin Shielding

 

Multiple sclerosis involves autoimmune destruction of the protective myelin sheath. Cannabinoid receptors (CB2) on microglial cells dampen pro-inflammatory cascades, mitigating demyelination and oxidative damage in brain and spinal tissue.

 
 
 Spasm Mitigation
 

#### ⚡ Central Spasticity & Motor Equilibrium

 

Excessive motor tone and involuntary spastic contractions stem from damaged inhibitory pathways. Cannabinoids bind CB1 receptors in the basal ganglia and cerebellum, restoring neuromuscular braking mechanisms to ease painful cramps.

 
 
 Nerve Pain Calming
 

#### 🔥 Neuropathic Fire Extinguishment

 

Standard analgesics (NSAIDs, opioids) often fail against peripheral neuropathic pain. Cannabinoids desensitize TRPV1 ion channels and downregulate allodynia signaling, calming burning, prickling, and electric shock sensations.

 
 
 Harm Reduction
 

#### 💊 De-Prescribing & Polypharmacy Relief

 

Many MS patients are trapped in toxic cycles of painkillers, anti-spasmodics, sleep aids, and antidepressants. Dr. Caplan helps patients systematically titrate botanical regimens to safely reduce pharmaceutical burdens.

 
 
 

 
 
 
 [▶](/videos/autism-pediatric-cannabinoid-therapy/)
 
 
 Neurodevelopmental Pediatrics Feature
 

#### Cannabis in Pediatric Autism: Speech Emergence & Calming Science

 

Explore our televised investigation on Boston 25 News and CBS News following young Joey in Massachusetts—overcoming severe meltdowns, achieving calm, and finding speech emergence through clinical cannabinoid protocols.

 [Watch Pediatric Autism Feature ↗](/videos/autism-pediatric-cannabinoid-therapy/)
 
 
 
 
 From Dr. Benjamin Caplan, MD
 

### Montel’s Courage Bridges Patient Experience and Frontline Medicine

 

“Montel Williams has spent more than two decades demonstrating that a multiple sclerosis diagnosis does not mean surrendering your mind or body to a pharmaceutical haze. Across our multiple discussions on Let’s Be Blunt, we have shown what happens when patients receive rigorous medical education rather than retail sales pitches. Whether managing severe central spasticity or weaning down from toxic opioids, evidence-grounded botanical medicine restores quality of life.”

 — Benjamin Caplan, MD | Chief Medical Officer, CĒD Clinic
 

 
 
 
 [▶](/videos/opioid-sparing-harm-reduction/)
 
 
 Public Health & Harm Reduction
 

#### Swapping Pills for Pot: Opioid Sparing & Harm Reduction

 

Watch 7News WHDH’s investigation into how chronic pain patients safely taper off addictive narcotics, sedatives, and toxic analgesics using physician-guided cannabinoid medicine.

 [Watch 7News Opioid Feature ↗](/videos/opioid-sparing-harm-reduction/)
 
 
 
 
 
 Video Network Directory
 

### Explore the CĒD Clinic Video Network

 

Discover our full library of clinical documentaries, broadcast investigations, and patient masterclasses.

 
 
 
 
 
 [Harm Reduction & Public Health
 ▶](/videos/opioid-sparing-harm-reduction/)
 
 
 

#### Swapping Pills for Pot: Opioid Sparing

 

7News WHDH investigation into how chronic pain patients safely taper off addictive narcotics, sedatives, and NSAIDs using physician-guided cannabis.

 
 
 
 [Watch 7News Feature ↗](/videos/opioid-sparing-harm-reduction/)
 
 
 
 
 
 [Survivor Series Feature
 ▶](/videos/cancer-survivorship-ethan-zohn/)
 
 
 

#### Ethan Zohn & Dr. Caplan: Cancer Recovery

 

6-part video masterclass with Survivor winner Ethan Zohn exploring chemotherapy nausea, neuropathies, radiation recovery, and post-remission PTSD.

 
 
 
 [Watch 6-Part Series ↗](/videos/cancer-survivorship-ethan-zohn/)
 
 
 
 
 
 [Pediatric & Autism Science
 ▶](/videos/autism-pediatric-cannabinoid-therapy/)
 
 
 

#### Pediatric Autism & Cannabinoid Therapy

 

CBS Boston & Boston 25 News investigation with Dr. Caplan exploring [autism spectrum disorder](https://cedclinic.com/cbd-gummies-autism-symptoms-clinical/), sensory overwhelm, and pediatric clinical protocols.

 
 
 
 [Watch Autism Series ↗](/videos/autism-pediatric-cannabinoid-therapy/)
 
 
 
 
 
 [Complete Media Archive
 ▶](/videos/)
 
 
 

#### The Master Media Timeline (2018–2026)

 

Full chronological continuum assembling televised leadership across FOX 5 DC, CBS News WBZ, NBC Boston, congressional hearings, and Harvard lectures.

 
 
 
 [Explore Master Timeline ↗](/videos/)
 
 
 
 
 
 
 Neurological Care Guidance
 

## Consult on Multiple Sclerosis & Neuropathy Care

 

Managing progressive neurological illness requires individualized physician oversight, careful medication interaction checks, and personalized titration. Schedule a consultation with Dr. Benjamin Caplan today.

 
 [Schedule Your Clinical Consultation ↗](https://cedclinic.com/contact-ced-staff/)
 [Explore Full Media Timeline ↗](/videos/)
 
 
 

 
 
 Oxford CEBM Graded Research
 

### Recent Clinical Trials & Peer-Reviewed Evidence: Multiple sclerosis

 

Clinical studies analyzed and contextualized by Benjamin Caplan, MD (CED Clinic Chief Medical Officer)

 

 
 
 
 Oxford CEBM Level 1A: Systematic Review & Meta-Analysis
 Medical Sciences (2026)
 
 

#### Nabiximols in Multiple Sclerosis: Beyond Spasticity—An Exploratory Systematic Review and Meta-Analysis of Symptomatic Outcomes

 

This review suggests the spray may ease several symptoms beyond stiffness in people with multiple sclerosis, but it does not prove it works for them. The studies were of mixed quality and many were not randomized co...

 
 [Read Physician Analysis & View Citations →](https://cedclinic.com/research/cbd-for-multiple-sclerosis-meta-analysis/)
 
 
 
 
 Clinical Evidence Analysis
 Cardiovascular research (2015)
 
 

#### Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation

 

This study does not change clinical practice for medical cannabis clinics.

 
 [Read Physician Analysis & View Citations →](https://cedclinic.com/research/cbd-for-vasodilation/)
 
 
 

 
 [Explore all peer-reviewed research on Multiple sclerosis in the Research Hub →](https://cedclinic.com/research-condition/multiple-sclerosis/)

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).